Good Science and Merck

Merck acknowledged Tuesday that a statistical analysis test used to reach the conclusion, published in a March 2005 New England Journal of Medicine article, did not support its theory of potential heart problems only after 18 months of continuous Vioxx use. The test actually showed there was 7 percent chance that Vioxx posed an equally high heart attack risk before and after the 18-month window, the Times reported.